These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11401078

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Imaging in lung cancer: positron emission tomography scan.
    Vansteenkiste JF.
    Eur Respir J Suppl; 2002 Feb; 35():49s-60s. PubMed ID: 12064681
    [Abstract] [Full Text] [Related]

  • 3. Value of FDG-PET in the management of non-small cell lung cancer.
    Stroobants S, Verschakelen J, Vansteenkiste J.
    Eur J Radiol; 2003 Jan; 45(1):49-59. PubMed ID: 12499064
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.
    Aquino SL, Asmuth JC, Alpert NM, Halpern EF, Fischman AJ.
    J Comput Assist Tomogr; 2003 Jan; 27(4):479-84. PubMed ID: 12886128
    [Abstract] [Full Text] [Related]

  • 6. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL, Fischman AJ.
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response.
    Truong MT, Viswanathan C, Erasmus JJ.
    J Thorac Imaging; 2011 May; 26(2):132-46. PubMed ID: 21508735
    [Abstract] [Full Text] [Related]

  • 10. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J, Khalil AA, Hjorthaug K, Frøkiaer J.
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
    Miele E, Spinelli GP, Tomao F, Zullo A, De Marinis F, Pasciuti G, Rossi L, Zoratto F, Tomao S.
    J Exp Clin Cancer Res; 2008 Oct 17; 27(1):52. PubMed ID: 18928537
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Positron emission tomography imaging in nonsmall-cell lung cancer.
    Erasmus JJ, Macapinlac HA, Swisher SG.
    Cancer; 2007 Nov 15; 110(10):2155-68. PubMed ID: 17896784
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE.
    Dis Colon Rectum; 2000 Jun 15; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.